SEC Form 4 · accession 0001178913-26-003706
COMPUGEN LTD · CGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle Mahler
Officer — Chief Medical Officer
Period of report
Jul 29, 2026
Accepted (ET)
Jul 30, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001119774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 29, 2026 | A | 13,500 | $0.00 | A | 36,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F2 | $2.26 | Jul 29, 2026 | A | 18,000 | A | — | Jul 29, 2036 | Ordinary Shares | 18,000 | 18,000 | D |
Explanation of responses
- F1Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F2This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.